EP3270966
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT OF CANCER WHEREIN THE COMBINATION DOES NOT COMPRISE 5-AZACYTIDINE.
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.3.2016EP published:
1.5.2024EP application number:
16769460.3
EPO information:
European Patent Register
Max expiry date:
17.3.2036
Title in English:
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT OF CANCER WHEREIN THE COMBINATION DOES NOT COMPRISE 5-AZACYTIDINE.Language of the patent:
English
Timeline
Today
18.3.2016EP application
1.5.2024EP Publication
Owner
Name:
Syndax Pharmaceuticals Inc.Address:
400 Totten Pond Road Suite 110, Waltham, MA 02451, US
Inventor
Name:
GOODENOW, RobertAddress:
San Clemente, California 92672, US
Name:
ORDENTLICH, PeterAddress:
Waltham, Massachusetts 02451, US
Priority
Number:
201562136303 PDate:
20.3.2015Country:
US
Number:
201562137601 PDate:
24.3.2015Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00, A61K 31/4406